Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 25th:
CrossAmericaPartners LP (CAPL - Free Report) : This wholesale distributor of motor fuel and real estate leasing company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 100% over the last 60 days.
CrossAmerica Partners LP Price and Consensus
CrossAmerica’s shares gained 22.2% over the last one month more than S&P 500’s gain of 7.1%. The company possesses a Momentum Score of A.
CrossAmerica Partners LP Price
ABIOMED, Inc. : This developer and seller of medical devices has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
ABIOMED, Inc. Price and Consensus
ABIOMED’s shares gained 13.4% over the last one month. The company possesses a Momentum Score of A.
ABIOMED, Inc. Price
AC Immune SA (ACIU - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 50.6% over the last 60 days.
AC Immune SA Price and Consensus
AC Immune’s shares gained 7.2% over the last one month. The company possesses a Momentum Score of A.
AC Immune SA Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 25th:
CrossAmericaPartners LP (CAPL - Free Report) : This wholesale distributor of motor fuel and real estate leasing company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 100% over the last 60 days.
CrossAmerica Partners LP Price and Consensus
CrossAmerica’s shares gained 22.2% over the last one month more than S&P 500’s gain of 7.1%. The company possesses a Momentum Score of A.
CrossAmerica Partners LP Price
ABIOMED, Inc. : This developer and seller of medical devices has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
ABIOMED, Inc. Price and Consensus
ABIOMED’s shares gained 13.4% over the last one month. The company possesses a Momentum Score of A.
ABIOMED, Inc. Price
AC Immune SA (ACIU - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 50.6% over the last 60 days.
AC Immune SA Price and Consensus
AC Immune’s shares gained 7.2% over the last one month. The company possesses a Momentum Score of A.
AC Immune SA Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on CAPL - FREE
Get the latest research report on ACIU - FREE